PRE-MARKET INDIAN STOCK NEWS: Sun Pharma seeking financing options, LT IS Q4 profit falls, RIL IS plans low earth orbit investment
India
Ajanta Pharma (AJP IS) - Co. net profit rose 18.7% Y/Y to INR 2.67bln and revenue rose 21.5% Y/Y to INR 14.22bln. (Moneycontrol)
Bharti Airtel (BHARTI IS) - Co. is exploring network slicing to offer differentiated premium voice and data plans to subscribers to monetise its 5G infrastructure. (Economic Times)
Biocon (BIOS IS) - Co. founder and chairperson Kiran Mazumdar-Shaw named Claire Mazumdar as her successor, while saying the succession will be gradual. (Economic Times)
Coforge (COFORGE IS) - Co. net profit rose 145% Y/Y to INR 6.12bln and revenue rose 5% Y/Y to INR 44.50bln. (Moneycontrol)
Emcure Pharmaceuticals (EMCURE IS) - Co. plans to step up investments in domestic expansion, R&D and manufacturing while assessing acquisition opportunities. (Economic Times)
Hero MotoCorp (HMCL IS) - Co. Q4 revenue rose 29% Y/Y to INR 127.97bln from INR 99.39bln. (Economic Times)
KEC International (KECI IS) - Co. secured new orders worth INR 10.02bln across transmission and distribution, renewable energy and transportation. (Economic Times)
Larsen and Toubro (LT IS) - Co. Q4 consolidated net profit fell 3% Y/Y to INR 53.26bln and recommended a final dividend of INR 38/shr. (Economic Times)
Mahindra and Mahindra (MM IS) - Co. net profit fell 3.1% Y/Y to INR 53.26bln and revenue rose 11.3% Y/Y to INR 827.62bln. (Moneycontrol)
Marico (MRCO IS) - Co. reported a healthy March-quarter performance helped by strong India volume growth and continued international momentum, while recommending a final dividend of INR 4/shr for FY26. (Economic Times)
Poonawalla Fincorp (POONAWAL IS) - Co. Q4 profit after tax rose 70% Q/Q to INR 2.55bln from INR 1.50bln, helped by sequential margin improvement, higher lending income and stable asset quality. (Economic Times)
Punjab National Bank (PNB IS) - Co. reported a 14% profit jump for Q4 FY26, said one in three loans are sanctioned digitally, digital sanctions crossed INR 1tln and digital transactions now exceed 95% of total transactions. (Economic Times)
Reliance Industries (RIL IS) - Co. plans a multi-billion dollar investment in the low earth orbit segment as part of a significant entry into satellite communications. (Economic Times)
Sun Pharmaceuticals (SUNP IS) – Co. is reportedly seeking consent from Organon bondholders to swap their holdings into Sun Pharma debt, according to Bloomberg, citing sources, as the Co. weighs multiple financing options for its proposed USD 12bln acquisition. (Bloomberg)
Zee Entertainment Enterprises (Z IS) - Co. filed a copyright violation case against FSN E-Commerce Ventures, the owner of Nykaa, in the Delhi High Court. (Economic Times)
Sun Pharmaceuticals is actively pursuing multiple financing options for a proposed $12 billion acquisition, which suggests it is positioning itself for significant growth, albeit with potential risks related to the high debt level. The market may react cautiously to this news as it underscores the company's aggressive strategy, contrasting with the modest profit fall for Larsen & Toubro, which could signal pressure in the construction sector. Overall, these developments reflect a mixed sentiment across the Indian market, with implications for stock performances in the pharmaceutical and construction sectors.